Stocks
Atara Biotherapeutics (ATRA) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | -331.1 | -222.3 | -266.0 | -75.7 | 38.6 | -5.54 | |
| Changes by years, y/y, % | +12% | -33% | +20% | -72% | -151% | |||
Atara Biotherapeutics. EBITDA US GAAP, bln rub
Atara Biotherapeutics. EBITDA US GAAP, changes, %
Atara Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Atara Biotherapeutics (ATRA) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 40.8 | 3.60 | -3.33 | -2.46 | -3.34 | -5.54 | |
| Changes by years, y/y, % | -240% | -122% | -83% | -77% | -108% | |||
| Changes by quarters, q/q, % | -485% | -91% | -193% | -26% | +36% | |||
